LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.
Save up to 30% on print and eBooks.
This volume of International Review of Neurobiology brings together cutting-edge research on advances in the neurochemistry and neuropharmacology of Tourette syndrome. It reviews c… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
This volume of International Review of Neurobiology brings together cutting-edge research on advances in the neurochemistry and neuropharmacology of Tourette syndrome. It reviews current knowledge and understanding, provides a starting point for researchers and practitioners entering the field, and includes important topics regards tics, neurotransmitters, pharmacology and emerging treatments.
Neuroscientists, psychologists, neurologists
Series Page
Contributors
Preface: The Metamorphoses of Gilles de la Tourette Syndrome
References
Chapter One. An Introduction to the Clinical Phenomenology of Tourette Syndrome
Abstract
1 Basic Nosography of Primary Tic Disorders
2 Phenomenology
References
Chapter Two. Functional Neuroanatomy of Tics
Abstract
1 Introduction
2 Structural Abnormalities
3 Functional Findings
4 Tics—A Matter of Connectivity?
Acknowledgments
References
Chapter Three. Functional Imaging of Dopaminergic Neurotransmission in Tourette Syndrome
Abstract
1 Introduction
2 Imaging of Cerebral Glucose Metabolism and Cerebral Blood Flow
3 Role of Dopaminergic Modulation in TS
4 The Role of Other Neurotransmitter Systems in TS
5 Conclusion
Acknowledgments
References
Chapter Four. Nondopaminergic Neurotransmission in the Pathophysiology of Tourette Syndrome
Abstract
1 Introduction
2 Role of the Monoamines Norepinephrine and Serotonin
3 Role of the Monoamine Histamine
4 Role of Glutamate
5 Role of GABA
6 Role of ACh
7 Role of Endocannabinoid
8 Role of Corticoid
9 Conclusion
References
Chapter Five. Reinforcement Learning and Tourette Syndrome
Abstract
Abbreviations
1 Reinforcement Learning: Concepts, and Paradigms
2 Neural Correlates of Reinforcement Learning
3 Tourette Syndrome and Reinforcement Learning
4 Conclusions and Perspectives
Acknowledgments
References
Chapter Six. Genetic Susceptibility and Neurotransmitters in Tourette Syndrome
Abstract
1 Introduction
2 Neurotransmitter Abnormalities Associated with TS
3 Neurotransmitter-Related Genetic Findings
4 Histamine-Related Genetic Findings
5 Neurotransmitter-Related Gene Expression Studies of Blood
6 Conclusion and Future Studies
References
Chapter Seven. Pharmacological Animal Models of Tic Disorders
Abstract
Abbreviations
1 Introduction
2 Validity Criteria for Developing Animal Models
3 Animal Models of Tic Disorders
4 Concluding Remarks and Future Perspectives
References
Chapter Eight. Animal Models Recapitulating the Multifactorial Origin of Tourette Syndrome
Abstract
1 Tic Disorders and Tourette Syndrome
2 Tourette Syndrome: Etiological Factors
3 Animal Models of TS
4 Future Perspectives
Acknowledgments
References
Chapter Nine. Neuroendocrine Aspects of Tourette Syndrome
Abstract
1 Introduction
2 Sex Steroid Hormones and TS
3 The Stress Response in TS
4 Neurohypophysial Peptides: Possible Players in the Complex Pathophysiology of TS?
5 Conclusions
References
Chapter Ten. Clinical Pharmacology of Dopamine-Modulating Agents in Tourette’s Syndrome
Abstract
1 Introduction
2 DA Receptor Antagonists
3 Systematic Review of Dopamine Receptor Antagonists in the Treatment of TS
4 Tetrabenazine
5 Dopamine Agonists
6 Summary
References
Chapter Eleven. Clinical Pharmacology of Nondopaminergic Drugs in Tourette Syndrome
Abstract
1 Introduction
2 Alpha2 Receptor Agonists
3 GABA Agonists
4 Cannabinoids
5 Botulinum Toxin
6 Tetrabenazine
7 Nicotine
8 Acetylcholinesterase Inhibitors
9 Immunoglobulins, Plasmapheresis, and Antibiotics
10 Summary and Future Research
References
Further-Reading
Chapter Twelve. Antiepileptic Drugs and Tourette Syndrome
Abstract
1 Introduction
2 TS: From Motion to Emotion
3 Pharmacological Treatments for Tics
4 Treatment with AEDs
5 Discussion
Acknowledgments
References
Chapter Thirteen. Clinical Pharmacology of Comorbid Obsessive–Compulsive Disorder in Tourette Syndrome
Abstract
1 Introduction
2 Obsessive–Compulsive Disorder
3 Treatment of Obsessive–Compulsive Disorder
4 Conclusions
References
Chapter Fourteen. Clinical Pharmacology of Comorbid Attention Deficit Hyperactivity Disorder in Tourette Syndrome
Abstract
1 Introduction
2 Diagnosis and Assessment
3 Overview of Therapeutic Interventions
4 Pharmacological Treatment Options
5 Pharmacotherapy Options Can Be Divided into Three Tiers with First-Tier Drugs Considered First-Choice Treatments
6 Adverse Effects
7 Conclusive Remarks
References
Chapter Fifteen. Emerging Treatment Strategies in Tourette Syndrome: What’s in the Pipeline?
Abstract
1 Introduction
2 Potential and Emerging Pharmacological Treatments
3 Potential and Emerging Nonpharmacological Treatments
4 Conclusion
References
Chapter Sixteen. Tics and Other Stereotyped Movements as Side Effects of Pharmacological Treatment
Abstract
1 General Considerations
2 Tics and Stereotyped Movements After Antipsychotic Exposure
3 Secondary Tics After Treatment with Psychostimulants
4 Tics and Stereotyped Movements and Antiepileptic Drugs
References
Index
Contents of Recent Volumes
DM
AC